Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Terracciano

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 28, 2020
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthmaCorrado Pelaia, Maria Teresa Busceti, Claudia Crimi, et al.
Journal of Translational Medicine|March 24, 2024
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPDSerena Correnti, Mariaimmacolata Preianò, Fabia Gamboni, et al.
Biomedicines|May 28, 2022
Novel Biological Therapies for Severe Asthma EndotypesCorrado Pelaia, Giulia Pelaia, Claudia Crimi, et al.
SAGE Open Medical Case Reports|February 29, 2020
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthmaCorrado Pelaia, Maria Teresa Busceti, Alessandro Vatrella, et al.
Cell Cycle (Georgetown, Tex.)|October 22, 2008
Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cellsNatalia Malara, Domenico Focà, Francesca Casadonte, et al.
Pharmacological Research|November 5, 2019
New treatments for asthma: From the pathogenic role of prostaglandin D<sub>2</sub> to the therapeutic effects of fevipiprantCorrado Pelaia, Claudia Crimi, Alessandro Vatrella, et al.
Biomed Research International|June 5, 2014
Application of proteomics and peptidomics to COPDGirolamo Pelaia, Rosa Terracciano, Alessandro Vatrella, et al.
Proteomics|July 14, 2011
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseasesRosa Terracciano, Mariaimmacolata Preianò, Grazia P Palladino, et al.
Proteomics. Clinical Applications|April 1, 2018
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MSMariaimmacolata Preianò, Giuseppina Maggisano, Maria Stella Murfuni, et al.
BMC Pharmacology & Toxicology|November 30, 2014
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxideLuca Gallelli, Daniela Falcone, Monica Scaramuzzino, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 28, 2020
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthmaCorrado Pelaia, Maria Teresa Busceti, Claudia Crimi, et al.
Journal of Translational Medicine|March 24, 2024
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPDSerena Correnti, Mariaimmacolata Preianò, Fabia Gamboni, et al.
Biomedicines|May 28, 2022
Novel Biological Therapies for Severe Asthma EndotypesCorrado Pelaia, Giulia Pelaia, Claudia Crimi, et al.
SAGE Open Medical Case Reports|February 29, 2020
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthmaCorrado Pelaia, Maria Teresa Busceti, Alessandro Vatrella, et al.
Cell Cycle (Georgetown, Tex.)|October 22, 2008
Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cellsNatalia Malara, Domenico Focà, Francesca Casadonte, et al.
Pharmacological Research|November 5, 2019
New treatments for asthma: From the pathogenic role of prostaglandin D<sub>2</sub> to the therapeutic effects of fevipiprantCorrado Pelaia, Claudia Crimi, Alessandro Vatrella, et al.
Biomed Research International|June 5, 2014
Application of proteomics and peptidomics to COPDGirolamo Pelaia, Rosa Terracciano, Alessandro Vatrella, et al.
Proteomics|July 14, 2011
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseasesRosa Terracciano, Mariaimmacolata Preianò, Grazia P Palladino, et al.
Proteomics. Clinical Applications|April 1, 2018
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MSMariaimmacolata Preianò, Giuseppina Maggisano, Maria Stella Murfuni, et al.
BMC Pharmacology & Toxicology|November 30, 2014
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxideLuca Gallelli, Daniela Falcone, Monica Scaramuzzino, et al.
Pageof 7